Celltrion to boost biosimilar business

Celltrion Inc., the largest biopharmaceutical contract manufacturer in Asia, said in its regulatory filing on April 22 that the company has signed a contract with Singapore's state-run Temasek Holdings to receive $200 million from the latter.

Under Temasek’s investment, Celltrion plans to expand the existing production capacity of its biological raw materials, while fucusing on the research ...